Here’s some interesting news: Greenpeace has come out forcefully against the growing Science/Industrial Complex in Germany (which, by the way, has a more “conservative” ESCR policy than the USA). It sued to prevent a German scientist from patenting a process for turning an embryonic stem cell into a nerve cell. The court ruled that anything made from human tissue cannot be patented.
The idea that big corporations should be able to “own” genes and patent human tissues is absurd—and in my view dangerous. But there are two schools of thought. Both are ably presented in this article.
The position against patents: “Greenpeace said that such patents aren’t intended to help research, but only to help make research profitable. ‘We believe there should be a clear separation between research and patenting products. And the court decision affirmed this.’…’When medical treatments can be patented, there is a chance that treatments will be delayed or will cost more,’ said Otmar Kloiber, Chairman of the World Medical Association. He cited a case a few years ago when a breast cancer-suppressing gene was patented. ‘As soon as the patent went through, the price for the treatment skyrocketed so that some insurance companies in the US were no longer able to cover the cost of treatment.’
The position in favor of patents: “Daniel Besser, a stem cell researcher at the Max Delbruck Center in Berlin, takes a different approach. ‘It also costs a lot to develop this technology,’ said Besser. ‘Which branch of the industry can be expected to invest billions in their research and then make the information available for everyone to use for free?’”
This whole issue kicks in my Naderite reflexes. I am very uncomfortable with any corporation or private person “owning” a human body part. The process by which, say a gene can be isolated, yes. The gene itself, no.
This also points the way toward stopping human cloning. If they can’t get patents, they won’t try to clone human organisms. In this regard, I see another opportunity for a left/right strange bedfellow political coalition that might just be effective in preventing the worst abuses of the coming biotech century.
Dear Reader,
Can I be direct with you?
War abroad. Socialists on the rise. AI upending human life. Endless uproar online. The modern attention economy doesn’t want readers — it wants users enslaved to the tyranny of the present.
First Things is the antidote: literary excellence, timeless truths, and a fixed point of reference in a culture that has lost its bearings.
But we can’t do it without readers like you.
Our goal: Raise $150,000 by November 1 to sustain First Things in the year ahead.
Your gift anchors readers in the permanent things.
Make your Fall Campaign gift now using the button below.
If you have any questions or would like more information, please contact Giovanni Del Piero, Director of the Editor’s Circle, at gdelpiero@firstthings.com or 212-627-1985.
YOU MIGHT ALSO LIKE
The Church in the Age of Therapy
In 1966, Philip Rieff wrote in The Triumph of the Therapeutic that “Religious man was born to…
Canada’s Deadliest Blind Spot
On September 20, the Daily Mail ran a story with the provocative headline, “Our 83-year-old Christian grandmother…
The Faithful Joy of Dolly Parton and Fulton Sheen
Dolly Parton and Fulton Sheen seem to have had little in common. She favored rhinestones; he wore…
